ARTICLE | Company News
Myogen, Abbott Laboratories Inc. deal
December 3, 2001 8:00 AM UTC
Myogen received an exclusive worldwide license from ABT to develop and market the endothelin receptor antagonist BSF 208075. Myogen previously entered an agreement to develop the compound with Knoll A...